Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Lifecore Biomedical Inc (LFCR)

Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 191,938
  • Shares Outstanding, K 30,322
  • Annual Sales, $ 103,270 K
  • Annual Income, $ -99,560 K
  • 60-Month Beta 1.03
  • Price/Sales 1.89
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade LFCR with:

Options Overview Details

View History
  • Implied Volatility 77.83% ( -22.23%)
  • Historical Volatility 122.87%
  • IV Percentile 9%
  • IV Rank 29.14%
  • IV High 143.43% on 04/05/24
  • IV Low 50.86% on 12/01/23
  • Put/Call Vol Ratio 0.40
  • Today's Volume 176
  • Volume Avg (30-Day) 92
  • Put/Call OI Ratio 0.59
  • Today's Open Interest 3,377
  • Open Int (30-Day) 3,678

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 02/29/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.22
  • Growth Rate Est. (year over year) +454,190.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.99 +33.07%
on 03/26/24
6.75 -1.63%
on 04/25/24
+1.24 (+22.96%)
since 03/25/24
3-Month
4.50 +47.56%
on 03/20/24
8.90 -25.39%
on 02/09/24
+0.14 (+2.15%)
since 01/25/24
52-Week
4.06 +63.55%
on 04/27/23
11.45 -42.03%
on 08/09/23
+2.26 (+51.60%)
since 04/25/23

Most Recent Stories

More News
SHL Medical and Lifecore Biomedical enter co-marketing partnership agreement

/PRNewswire/ -- SHL Medical ("SHL"), a world-leading solutions provider of advanced drug delivery systems such as autoinjectors and innovative specialty...

LFCR : 6.64 (+4.90%)
SHL Medical and Lifecore Biomedical enter co-marketing partnership agreement

/CNW/ -- SHL Medical ("SHL"), a world-leading solutions provider of advanced drug delivery systems such as autoinjectors and innovative specialty delivery...

LFCR : 6.64 (+4.90%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lifecore Biomedical, Inc. - LFCR

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Lifecore Biomedical, Inc. ("Lifecore" or the "Company") (NASDAQ: LFCR). Such...

LFCR : 6.64 (+4.90%)
Stock Index Futures Move Lower as U.S. Debt Ceiling Uncertainty Weighs on Sentiment, PMI Data in Focus

June S&P 500 futures (ESM23) are down -0.14%, and June Nasdaq 100 E-Mini futures (NQM23) are down -0.02% this morning as the U.S. debt ceiling impasse kept risk sentiment fragile, while market participants...

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
PACW : 7.54 (-2.71%)
NKE : 93.94 (-0.74%)
BAER.Z.IX : 48.770 (+1.06%)
MYGN : 17.98 (-3.49%)
LFCR : 6.64 (+4.90%)
MVST : 0.3882 (-13.69%)
GH : 17.16 (-5.19%)
QTRX : 15.59 (-2.81%)
Urogen Pharma (URGN) Reports Q1 Loss, Tops Revenue Estimates

Urogen Pharma (URGN) delivered earnings and revenue surprises of 6.47% and 3.88%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

URGN : 13.82 (-2.74%)
LFCR : 6.64 (+4.90%)
New Strong Sell Stocks for December 23rd

SGRP, LFCR and MD have been added to the Zacks Rank #5 (Strong Sell) List on December 23, 2022.

MD : 8.90 (-3.68%)
SGRP : 1.5900 (-9.14%)
LFCR : 6.64 (+4.90%)
Quipt Home Medical Corp. (QIPT) Beats Q4 Earnings Estimates

Quipt Home Medical Corp. (QIPT) delivered earnings and revenue surprises of 25% and 1.01%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

QIPT : 3.66 (-4.69%)
LFCR : 6.64 (+4.90%)
Avid Bioservices (CDMO) Reports Q2 Loss, Tops Revenue Estimates

Avid Bioservices (CDMO) delivered earnings and revenue surprises of 0% and 12.12%, respectively, for the quarter ended October 2022. Do the numbers hold clues to what lies ahead for the stock?

CDMO : 7.32 (+7.17%)
LFCR : 6.64 (+4.90%)
Veru Inc. (VERU) Reports Q4 Loss, Lags Revenue Estimates

Veru Inc. (VERU) delivered earnings and revenue surprises of -75.86% and 77.51%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

VERU : 1.2100 (-8.33%)
LFCR : 6.64 (+4.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Lifecore Biomedical Inc. is a fully integrated contract development and manufacturing organization which offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. Lifecore Biomedical Inc., formerly known...

See More

Key Turning Points

3rd Resistance Point 7.54
2nd Resistance Point 7.15
1st Resistance Point 6.89
Last Price 6.64
1st Support Level 6.24
2nd Support Level 5.85
3rd Support Level 5.59

See More

52-Week High 11.45
Fibonacci 61.8% 8.63
Fibonacci 50% 7.76
Fibonacci 38.2% 6.88
Last Price 6.64
52-Week Low 4.06

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar